This is in continuation to our letter dated September 22, 2021, regarding acquisition of stake in Wellversed Health Private Limited ('Wellversed') in terms of Regulation 30 of the Listing Regulations.\r\n\r\nAs agreed with Wellversed, the Company has disbursed the second tranche of investment of Rs. 3.5 Crores and accordingly the aforesaid acquisition has been completed effective May 2 2022. Consequentially, the Company's current effective shareholding in Wellversed is 27.81% and it is 25.02% on a fully diluted basis in the following manner:\r\n\r\na) 4,576 Compulsorily Convertible Preference Shares (CCPS) of face value of Rs. 10 each at a premium of Rs. 21,798.30 per CCPS;\r\nb) 10 fully paid up equity shares of face value of Rs. 10 each at a premium of Rs. 21,798.30 per share.\r\n\r\nThis is for your information and records.